羟甲基戊二酸单酰辅酶A(3-hydroxy-3-methylglutarylcoenzyme A,HMG-CoA)还原酶抑制剂,即他汀类药物,作为降脂的一线用药,在降低胆固醇、稳定粥样斑块、减少和预防冠状动脉粥样硬化性心脏病和缺血性脑卒中的发病中得到越来越多的应用,其安全性和有效性也得到很好的临床评价和实 Hydroxymethyl glutaryl coenzyme A (3-hydroxy-3-methylglutarylcoenzyme A, HMG-CoA) reductase inhibitors, namely statins, as a first-line lipid-lowering drugs, reduce cholesterol, stable plaque , Reducing and preventing the occurrence of coronary atherosclerotic heart disease and ischemic stroke are more and more applications, its safety and effectiveness have also been very good clinical evaluation and practice